Robert Heaps, MD
Orthopaedic Surgery · Nashua, NHNPI 1477599611
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (56.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Arthrex accounts for 66.1% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2020 at $1,913 and has fallen 83.4% since, to $318 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in NH, where the typical reported total is $2,654.
Across 35 payments — averaging $76.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Endo Pharmaceuticals Inc.$136
- Kairos Surgical Inc$130
- Zimmer Biomet$113
- Ferring Pharmaceuticals Inc.$98
- Bioventus LLC$81
- plus $356 from 10 others
What the payments were for
- Travel & lodging$2539%
- Food & beverage$90534%
- Education$1,53257%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 5 | $1,777 |
| Endo Pharmaceuticals Inc. | 4 | $136 |
| Kairos Surgical Inc | 2 | $130 |
| Zimmer Biomet | 2 | $113 |
| Ferring Pharmaceuticals Inc. | 6 | $98 |
| Bioventus LLC | 3 | $81 |
| Skeletal Dynamics Inc | 1 | $78 |
| Endo USA, Inc. | 3 | $74 |
| Vertex | 2 | $32 |
| Radius Health, Inc. | 1 | $31 |
| Amgen | 1 | $30 |
| Smith+Nephew | 1 | $28 |
| Solventum Corporation | 1 | $25 |
| Abbott | 1 | $22 |
| Pacira Therapeutics, Inc. | 1 | $20 |
| Orthofix Medical, Inc. | 1 | $19 |
How this compares
$2,690 in reported general payments places this provider in the 50th percentile of 141 orthopaedic surgery providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 39 | $214 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $87 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Nashua
- David RichardsNashua$122K
- Christian KlareNashua$88K
- Matthew WilkeningNashua$79K
- Thomas FortneyNashua$54K
- Peter EyvazzadehNashua$19K
- Anand PadmanabhaNashua$16K
- Bryan BeanNashua$11K
- Andrew GarberNashua$9K
- Jason SmoakNashua$8K
- James BargerNashua$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.